Inspection Results of the MHRA Published

From time to time, the MHRA (U.K. Medicines and Healthcare Products Regulatory Agency) publishes a summary of the results of the inspections conducted by the agency. Now, a presentation of the data gathered between April 2008 and March 2009 has been published.

During that period, a total of 359 inspections were performed, in which 33 so-called critical observations and 786 major observations were made.

Among the most frequent observations were:

1. Investigation of anomalies
2. Change Control
3. Investigation of Anomalies - CAPA
4. Complaints and recalls
5. Documentation: PSF and SOPs

On the following ranks, there are observations concerning product contamination, batch release, premises, PQR and supplier qualification.

The presentation also includes a comparison between the occurrence of subject-specific observations within Great Britain and those from overseas. Here one can see significant differences, above all with regard to premises, equipment and impurities, where overseas firms show a clearly poorer performance.

Compiled by
Wolfgang Schmitt
On behalf of the European Compliance Academy (ECA)

Cookies help us in providing our services. By using our services, you agree that we use cookies. Further information

OK

Conference Recommendations

Go back

GMP Conferences by Topics

Cookies help us in providing our services. By using our services, you agree that we use cookies. Further information

OK